Charles River Laboratories Intl. Inc vs TORM plc — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while TORM plc trades at $28.33 (market cap $2.93B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 4.6× TORM plc's market cap, and TORM plc pays a 9.77% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | TRMD | |
|---|---|---|
Market Cap | $13.46B | $2.93B |
Sector | Health | Technology |
52-Week High | $282.00 | $34.87 |
52-Week Low | $145.57 | $18.77 |
Enterprise Value | $16.30B | $3.82B |
Dividend Yield | — | 9.77% |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →